GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
-1.82%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$331M
AUM Growth
+$331M
(-4.5%)
Cap. Flow
-$15M
Cap. Flow
% of AUM
-4.53%
Top 10 Holdings %
Top 10 Hldgs %
38.48%
Holding
95
New
21
Increased
12
Reduced
19
Closed
26
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$17M |
| 2 |
Merck
MRK
|
$13.2M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$7.92M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$7.61M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$7.09M |
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$12.4M |
| 2 |
Edwards Lifesciences
EW
|
$10.2M |
| 3 |
Puma Biotechnology
PBYI
|
$10.1M |
| 4 |
Sarepta Therapeutics
SRPT
|
$9.21M |
| 5 |
CYNO
Cynosure, Inc. Class A
CYNO
|
$7.64M |
Sector Composition
| 1 | Healthcare | 91.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHPG
1
DELISTED
Shire pic
SHPG
| $17M | 4.1% | +100,000 | New | +$17M |
|
2
Abbott
ABT
$231B
| $15.4M | 3.7% | 400,000 +100,000 | +33% | +$3.84M |
|
|
ALXN
3
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $14.1M | 3.39% | 115,000 -5,000 | -4% | -$612K |
|
4
Zimmer Biomet
ZBH
$21B
| $13.4M | 3.23% | 130,000 +5,000 | +4% | +$516K |
|
|
5
Merck
MRK
$210B
| $13.2M | 3.19% | +225,000 | New | +$13.2M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $12.7M | 3.06% | 110,000 +10,000 | +10% | +$1.16M |
|
|
DBVT
7
DBV Technologies
DBVT
$264M
| $11.4M | 2.75% | 325,000 +75,000 | +30% | +$2.63M |
|
|
SAGE
8
DELISTED
Sage Therapeutics
SAGE
| $10.2M | 2.46% | 200,000 +25,000 | +14% | +$1.28M |
|
|
NUVA
9
DELISTED
NuVasive, Inc.
NUVA
| $10.1M | 2.43% | 150,000 -60,000 | -29% | -$4.04M |
|
|
CLVS
10
DELISTED
Clovis Oncology, Inc.
CLVS
| $9.77M | 2.35% | 220,000 -280,000 | -56% | -$12.4M |
|
11
Boston Scientific
BSX
$156B
| $9.73M | 2.34% | 450,000 +50,000 | +13% | +$1.08M |
|
|
AVXS
12
DELISTED
AveXis, Inc. Common Stock
AVXS
| $8.35M | 2.01% | 175,000 +148,464 | +559% | +$7.09M |
|
|
SPNC
13
DELISTED
Spectranetics Corp
SPNC
| $8.21M | 1.98% | 335,000 -100,000 | -23% | -$2.45M |
|
|
SGEN
14
DELISTED
Seagen Inc. Common Stock
SGEN
| $7.92M | 1.91% | +150,000 | New | +$7.92M |
|
|
ICPT
15
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $7.61M | 1.83% | +70,000 | New | +$7.61M |
|
|
NDRM
16
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $7.33M | 1.76% | 330,000 +199,000 | +152% | +$4.42M |
|
17
BioCryst Pharmaceuticals
BCRX
$1.74B
| $7.28M | 1.75% | 1,150,000 -650,000 | -36% | -$4.11M |
|
18
Glaukos
GKOS
$5.5B
| $6.86M | 1.65% | +200,000 | New | +$6.86M |
|
19
Iovance Biotherapeutics
IOVA
$807M
| $6.78M | 1.63% | 975,000 +150,000 | +18% | +$1.04M |
|
|
MNK
20
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $6.73M | 1.62% | +135,000 | New | +$6.73M |
|
|
AERI
21
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $6.62M | 1.59% | 175,000 +50,000 | +40% | +$1.89M |
|
|
NVRO
22
DELISTED
NEVRO CORP.
NVRO
| $6.54M | 1.57% | 90,000 +30,000 | +50% | +$2.18M |
|
|
IMMU
23
DELISTED
Immunomedics Inc
IMMU
| $6.24M | 1.5% | 1,700,000 -300,000 | -15% | -$1.1M |
|
|
AVDL
24
Avadel Pharmaceuticals
AVDL
$1.43B
| $5.97M | 1.44% | 575,000 | – | – |
|
25
Bristol-Myers Squibb
BMY
$96B
| $5.84M | 1.41% | +100,000 | New | +$5.84M |
|